Literature DB >> 3605230

Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis.

A H Tzamaloukas, P S Avasthi.   

Abstract

We analyzed routine serum potassium concentration measurements and conditions temporally associated with abnormalities in potassium concentration in outpatients on chronic hemodialysis (136 nondiabetics, 36 diabetics) and continuous ambulatory peritoneal dialysis (16 nondiabetics, 10 diabetics). The following potassium concentration frequencies were found: prehemodialysis, nondiabetics: normal 51.3%, severe hyperkalemia (greater than 6.0 mmol/l) 10%, severe hypokalemia (less than 3.0 mmol/l) 0.3%; diabetics: normal 57.8%, severe hyperkalemia 8.7%, severe hypokalemia 0.5%. Peritoneal dialysis, nondiabetics: normal 73.7%, severe hyperkalemia 0.6%, severe hypokalemia 4.9%; diabetics: normal 72.5%, severe hyperkalemia 0.9%, severe hypokalemia 2.9%. Normokalemia and severe hypokalemia were significantly (chi 2 test) more frequent in peritoneal dialysis than in prehemodialysis, whereas severe hyperkalemia was more frequent in prehemodialysis serum samples. No difference was found between nondiabetics and diabetics for either form of dialysis. 50% of prehemodialysis episodes of hyperkalemia were diet-induced. Hyperkalemic drugs and anuria were not associated with a higher risk of prehemodialysis hyperkalemia, but each one of 3 abnormalities, very high BUN (greater than 40 mmol/l), metabolic acidosis (TCO2 less than 15 mmol/l) and, in diabetics, severe hyperglycemia (serum glucose greater than 30 mmol/l), was associated with a statistically higher risk of hyperkalemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605230     DOI: 10.1159/000167443

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  17 in total

Review 1.  Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature.

Authors:  Effie Tziviskou; Carlos Musso; Vincenzo Bellizzi; Mukesh Khandelwal; Tao Wang; Shokoufeh Savaj; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 2.  Hyperkalemia in the Hypertensive Patient.

Authors:  Jay Ian Lakkis; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2018-03-01       Impact factor: 2.931

3.  Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.

Authors:  Sonal Korgaonkar; Anca Tilea; Brenda W Gillespie; Margaret Kiser; George Eisele; Fredric Finkelstein; Peter Kotanko; Bertram Pitt; Rajiv Saran
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

Review 4.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reports.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-09       Impact factor: 2.370

Review 5.  Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management.

Authors:  Shigeru Shibata; Shunya Uchida
Journal:  Ther Apher Dial       Date:  2021-08-31       Impact factor: 2.195

Review 6.  Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?

Authors:  David E St-Jules; David S Goldfarb; Mary Ann Sevick
Journal:  J Ren Nutr       Date:  2016-03-12       Impact factor: 3.655

7.  Nutritional Intake in Adult Hemodialysis Patients.

Authors:  Susan Stark; Linda Snetselaar; Beth Hall; Roslyn A Stone; Sunghee Kim; Beth Piraino; Mary Ann Sevick
Journal:  Top Clin Nutr       Date:  2011-01       Impact factor: 0.508

Review 8.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

9.  Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Joo-Hark Yi; Yeo-Wook Yun; Sang-Woong Han; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2009-06-30

10.  Icodextrin improves the serum potassium profile with the enhancement of nutritional status in continuous ambulatory peritoneal dialysis patients.

Authors:  Joo-Hark Yi; Jae-Il Park; Hoon-Young Choi; Ho-Yung Lee; Sang-Woong Han; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.